| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| TEVA Teva Pharmaceutical Industries Limited | 116,164,469,732.3 | 437,325,062,521.6 | 1,266,748,911,113.62 |
| BHC Bausch Health Companies Inc. | 58,002,779,004.5 | 207,284,451,872.52 | 788,011,453,500.04 |
| RDY Dr. Reddy's Laboratories Limited | 3,689,350,981.79 | 100,604,638,674.64 | 193,359,029,478.12 |
| 1795 美時 | 6,325,432,000 | 25,659,301,000 | 108,585,630,000 |
| AMPH Amphastar Pharmaceuticals, Inc. | 7,106,977,218.8 | 20,053,102,145.57 | 55,420,972,018.39 |
| 6472 保瑞 | 8,431,018,000 | 24,395,699,000 | 52,077,131,000 |
| SUPN Supernus Pharmaceuticals, Inc. | 5,719,328,268.6 | 22,994,399,232.13 | 45,388,652,450.05 |
| BBIO BridgeBio Pharma, Inc. | 21,545,601,050.81 | 34,742,488,676.94 | 38,688,616,372.27 |
| TSHA Taysha Gene Therapies, Inc. | 14,473,902,234.58 | 14,665,454,425.84 | 14,951,463,745.44 |
| 3705 永信 | 1,681,311,000 | 7,568,539,000 | 13,176,178,000 |
| 1720 生達 | 2,014,373,000 | 5,775,065,000 | 12,315,901,000 |
| 4120 友華 | 1,545,691,000 | 4,035,955,000 | 11,750,301,000 |
| ASMB Assembly Biosciences Inc | 1,026,124,779.69 | 10,423,909,836.9 | 10,514,616,648.56 |
| PSNL Personalis, Inc. | 2,986,523,363.01 | 7,788,327,123.62 | 9,920,382,150.45 |
| 4747 強生* | 261,729,000 | 602,886,000 | 2,558,703,000 |
| 6461 益得 | 95,420,000 | 370,571,000 | 2,295,483,000 |
| SLGL SOL-GEL TECHNOLOGIES LTD. | 529,557,426.72 | 1,623,473,947.58 | 1,708,491,719.54 |
| CPHI China Pharma Holdings Inc | 9,689,483.42 | 63,775,088.44 | 1,420,985,451.51 |
| 6130 上亞科技 | 75,442,000 | 178,444,000 | 735,886,000 |
載入數據中...
最新要聞
和學名藥相關的產業概念股
學名藥概念股相關指標排名
學名藥每月營收
學名藥每股盈餘
學名藥每股淨值
學名藥損益表
學名藥總資產
學名藥負債和股東權益
學名藥現金流量表
學名藥利潤比率
學名藥營業費用率拆解
學名藥杜邦分析
學名藥ROE / ROA
學名藥經營週轉能力
學名藥營運週轉天數
學名藥現金股利發放率
學名藥財務結構比率
學名藥流速動比率
學名藥利息保障倍數
學名藥現金流量分析
學名藥營業現金流對淨利比
學名藥盈餘再投資比率
學名藥月營收成長率
學名藥營收成長率
學名藥毛利成長率
學名藥營業利益成長率
學名藥稅後淨利成長率
學名藥每股盈餘成長率
學名藥本益比評價
學名藥股價淨值比評價
學名藥現金股利殖利率
學名藥平均現金股息殖利率
學名藥董監持股比例
學名藥董監持股質押比例